retatrutide clinical trial retatrutide weight loss information stage Results After 40: Realistic Timelines & FAQ Retatrutide Contraindications: Risks and Considerations – Retatrutide Helped Adults With Diabetes

Focus: Maintenance planning, establishing long-term strategy, evaluating results against goals

Obesity has been linked to worse outcomes in Crohn's disease and ulcerative colitis, and laboratory work suggested GLP-1 signaling might calm gut inflammation directly

Social pressure and diet culture may also play a role

11.7 Practical Takeaway Framework During GLP-1 therapy: Prioritise protein intake Increase micronutrient density per calorie Monitor symptoms Test selectively when risk factors are present Avoid automatic or excessive supplementation Reassess after significant weight milestones Weight loss should be metabolically effective and nutritionally sufficient

Augustine and St

Neither tirzepatide nor retatrutide should be combined with other GLP-1 agonists like semaglutide